Published in Cancer Weekly, December 17th, 2002
Their findings were presented at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Frankfurt, Germany.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.